Literature DB >> 31537893

Abicipar pegol-a novel anti-VEGF therapy with a long duration of action.

Elad Moisseiev1,2, Anat Loewenstein3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31537893      PMCID： PMC7265438          DOI： 10.1038/s41433-019-0584-y

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN： 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  7 in total

Review 1.  Targeting vascular endothelial growth factor using retinal gene therapy.

Authors:  Sook H Chung; Sonia L Frick; Glenn Yiu
Journal:  Ann Transl Med       Date:  2021-08

Review 2.  HER-2-Targeted Nanoparticles for Breast Cancer Diagnosis and Treatment.

Authors:  Leopoldo Sitia; Marta Sevieri; Lorena Signati; Arianna Bonizzi; Arianna Chesi; Francesco Mainini; Fabio Corsi; Serena Mazzucchelli
Journal:  Cancers (Basel)       Date:  2022-05-13       Impact factor: 6.575

Review 3.  Mechanisms of sterile inflammation after intravitreal injection of antiangiogenic drugs: a narrative review.

Authors:  William J Anderson; Natasha Ferreira Santos da Cruz; Luiz Henrique Lima; Geoffrey G Emerson; Eduardo Büchele Rodrigues; Gustavo Barreto Melo
Journal:  Int J Retina Vitreous       Date:  2021-05-07

Review 4.  Age-Related Macular Degeneration Revisited: From Pathology and Cellular Stress to Potential Therapies.

Authors:  Majda Hadziahmetovic; Goldis Malek
Journal:  Front Cell Dev Biol       Date:  2021-01-25

5.  Trends, geographical variation and factors associated with the use of anti-VEGF intravitreal injections in Portugal (2013-2018): a retrospective analysis of administrative data.

Authors:  João Victor Rocha; Ana Patricia Marques; Antonio Filipe Macedo; Marta Afonso-Silva; Pedro Laires; Ana Sofia Almeida; Julieta Fernandes; Marisa Pardal; Rui Santana
Journal:  BMJ Open       Date:  2022-04-06       Impact factor: 2.692

Review 6.  Aflibercept versus Faricimab in the Treatment of Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: A Review.

Authors:  Sławomir Liberski; Małgorzata Wichrowska; Jarosław Kocięcki
Journal:  Int J Mol Sci       Date:  2022-08-20       Impact factor: 6.208

7.  Profound Functional Suppression of Tumor-Infiltrating T-Cells in Ovarian Cancer Patients Can Be Reversed Using PD-1-Blocking Antibodies or DARPin® Proteins.

Authors:  Emelie Foord; Charlotte Klynning; Esther Schoutrop; Judith M Förster; Jennifer Krieg; Anette Mörtberg; Mischa R Müller; Christel Herzog; Dieter Schiegg; Denis Villemagne; Ulrike Fiedler; Dan Snell; Benjamin Kebble; Jonas Mattsson; Victor Levitsky; Michael Uhlin
Journal:  J Immunol Res       Date:  2020-08-04       Impact factor: 4.818
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.